Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | SURROZEN INC SRZN | Perceptive Advisors LLC | 166,666 5.100% | 166,666 (New Position) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | ENSYSCE BIOSCIENCES INC PA ENSC | Perceptive Advisors LLC | 86,666 0.400% | -1 (-0.00%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | RAPT THERAPEUTICS INC RAPT | Perceptive Advisors LLC | 735,000 4.500% | 467,506 (+174.77%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | Perceptive Advisors LLC | 1,441,249 5.600% | -125,420 (-8.01%) | Filing History |
| 2025-02-14 4:15 pm Unchanged | 2024-12-31 | 13G | BIODESIX INC BDSX | Perceptive Advisors LLC | 333,694 4.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | APPLIED THERAPEUTICS INC APLT | Perceptive Advisors LLC | 2,860,000 2.400% | -7,145,000 (-71.41%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | Perceptive Advisors LLC | 163,935 2.500% | 12,502 (+8.26%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Perceptive Advisors LLC | 2,574,723 4.400% | -297,824 (-10.37%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | CELCUITY INC CELC | Perceptive Advisors LLC | 2,362,279 6.400% | 880,979 (+59.47%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | Perceptive Advisors LLC | 24,245,952 8.100% | -3,811,504 (-13.58%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Perceptive Advisors LLC | 6,774,348 7.900% | 2,315,607 (+51.93%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Perceptive Advisors LLC | 1,829,735 9.500% | 710,700 (+63.51%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 473,115 5.100% | -323,100 (-40.58%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | ANTERIS TECHNOLOGIES GLOBAL CO AVR | Perceptive Advisors LLC | 2,440,000 6.700% | 2,440,000 (New Position) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | ADAGIO MED INC ADGM | Perceptive Advisors LLC | 15,321,655 73.600% | 64,167 (+0.42%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | Perceptive Advisors LLC | 22,112,266 7.300% | -4,505,443 (-16.93%) | Filing History |
| 2025-01-31 9:06 pm Unchanged | 2025-01-31 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 12,594,211 10.000% | 0 (Unchanged) | Filing History |
| 2025-01-08 9:28 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 386,555 9.900% | 386,555 (New Position) | Filing History |
| 2024-12-16 9:02 pm Unchanged | 2024-12-12 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 255,151 19.500% | 0 (Unchanged) | Filing History |
| 2024-12-09 6:22 pm Purchase | 2024-12-05 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 796,215 8.700% | 86,297 (+12.16%) | Filing History |